Torres Amanda Vital, Corrêa Raquel da Silva, Bevilacqua Maria de Fátima, do Prado Luana Cristina França, Bandeira Flavia Miranda Gomes de Constantino, Rodrigues Luciana Silva, Gomes Marilia Brito
Diabetes Unit, Department of Internal Medicine, Faculty of Medical Science, Rio de Janeiro State University (UERJ), Rio de Janeiro, RJ, Brazil.
Laboratory of Immunopathology, Department of Pathology and Laboratories, Faculty of Medical Science, Rio de Janeiro State University (UERJ), Rio de Janeiro, RJ, Brazil.
Front Clin Diabetes Healthc. 2022 Aug 17;3:914574. doi: 10.3389/fcdhc.2022.914574. eCollection 2022.
Although several cohort studies have raised the important association between diabetes mellitus (DM) and latent tuberculosis infection (LTBI), evidences are limited and controversial. Furthermore, it is well documented that the poor glycemic control may exacerbate the risk for active TB. Thus, the monitoring of diabetic patients living in high-incidence areas for TB is an important concern in views of available diagnostic tests for LTBI. In this cross-sectional study, we estimate the association of DM and LTBI among diabetic patients classified as type-1 DM (T1D) or type-2 DM (T2D) living in Rio de Janeiro, RJ, Brazil - considered a high TB burden region of these country. Non-DM volunteers were included as endemic area healthy controls. All participants were screened for DM using glycosylated-hemoglobin (HbA) and for LTBI using the QuantiFERON-TB Gold in Tube (QFT-GIT). Demographic, socioeconomic, clinical and laboratorial data were also assessed. Among 553 included participants, 88 (15.9%) had QFT-GIT positive test, of which 18 (20.5%) were non-DM, 30 (34.1%) T1D and 40 (45.4%) T2D. After adjustments for potential baseline confounders, age, self-reported non-white skin color and an active TB case in the family were significantly associated with LTBI among the studied population by using a hierarchical multivariate logistic regression analysis. Additionally, we verified that T2D patients were able to produce significant increased interferon-gamma (IFN-γ) plasma levels in response to -specific antigens, when compared to non-DM individuals. Altogether, our data showed an increased prevalence of LTBI among DM patients, albeit non-statistically significant, and point out to important independent factors associated with LTBI, which deserve attention in monitoring patients with DM. Moreover, QFT-GIT test seems to be a good tool to screening LTBI in this population, even in a high TB burden area.
尽管多项队列研究提出了糖尿病(DM)与潜伏性结核感染(LTBI)之间的重要关联,但证据有限且存在争议。此外,有充分记录表明血糖控制不佳可能会增加活动性结核病的风险。因此,鉴于现有的LTBI诊断测试,对生活在结核病高发地区的糖尿病患者进行结核病监测是一个重要问题。在这项横断面研究中,我们评估了巴西里约热内卢(RJ)地区被分类为1型糖尿病(T1D)或2型糖尿病(T2D)的糖尿病患者中DM与LTBI的关联,里约热内卢被认为是该国结核病负担较重的地区。非糖尿病志愿者被纳入作为流行地区健康对照。所有参与者均使用糖化血红蛋白(HbA)筛查DM,并使用全血γ-干扰素释放试验(QFT-GIT)筛查LTBI。还评估了人口统计学、社会经济、临床和实验室数据。在纳入的553名参与者中,88人(15.9%)QFT-GIT检测呈阳性,其中18人(20.5%)为非糖尿病患者,30人(34.1%)为T1D患者,40人(45.4%)为T2D患者。在对潜在的基线混杂因素进行调整后,通过分层多变量逻辑回归分析,年龄、自我报告的非白色肤色以及家中有活动性结核病例在研究人群中与LTBI显著相关。此外,我们证实,与非糖尿病个体相比,T2D患者在对特异性抗原作出反应时能够产生显著升高的血浆γ-干扰素(IFN-γ)水平。总之,我们的数据显示DM患者中LTBI的患病率有所增加,尽管无统计学意义,并指出了与LTBI相关的重要独立因素,这些因素在监测DM患者时值得关注。此外,QFT-GIT检测似乎是在该人群中筛查LTBI的良好工具,即使在结核病负担较重的地区也是如此。